Search
Barium sulfate
go.drugbank.com/drugs/DB11150ApprovedBarium sulfate is ingested by mouth or administered rectally and combined with granules of effervescent bicarbonate to enhance distension of the GI tract, allowing for enhanced gastrointestinal tract visualization
Products: Micropaque CT 50 mg/ml Konzentrat für orale Suspension, Scannotrast - Konzentrat für orale und rektale SuspensionMethoxy polyethylene glycol-epoetin beta
go.drugbank.com/drugs/DB09107ApprovedInvestigationalMethoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease...
Products: MIRCERA 50UG 0.3ML FER, MIRCERA 100UG 0.3ML FERAmsacrine
go.drugbank.com/drugs/DB00276ApprovedInvestigationalWithdrawnAminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in c...
Products: Amlyo 75 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Amsidyl 75 mg/1,5 ml Konzentrat und Lösungsmittel für ein Konzentrat zur Herstellung einer InfusionslösungCefaclor
go.drugbank.com/drugs/DB00833ApprovedInvestigationalSemisynthetic, broad-spectrum antibiotic derivative of cephalexin.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Ceclor 125 mg/5ml - Granulat für orale Suspension, Ceclor 250 mg/ 5 ml - Granulat für orale SuspensionInsulin human
go.drugbank.com/drugs/DB00030ApprovedInvestigationalAbsorption of glucose into cells allows for its transformation into glycogen or fat for storage. … Afrezza does not currently have Health Canada or European Medicines Agency approval for marketing in Canada or the EU.
Mixtures: ACTRAPHANE 30 INNOLET FER, ACTRAPHANE 30 INNOLET FERCategories: Insulins and Analogues for Injection, Fast-ActingCeftobiprole medocaril
go.drugbank.com/drugs/DB14733Approvedfor skin and skin structure infections and bacteremia in April 2024. … The EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion of ceftobiprole medocaril in February 2010, recommending the refusal of its marketing authorization in the European
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Zevtera 500 mg Pulver für ein Konzentrat zur Herstellung einer InfusionslösungIron
go.drugbank.com/drugs/DB01592ApprovedInvestigationalA metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transp...
Mixtures: For-2, Supplement De FerSynonyms: ferClarithromycin
go.drugbank.com/drugs/DB01211ApprovedInvestigationalClarithromycin, a semisynthetic macrolide antibiotic derived from erythromycin, inhibits bacterial protein synthesis by binding to the bacterial 50S ribosomal subunit. Binding inhibits peptidyl transferase activity and interferes with am...
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Klacid 125 mg/5 ml - Granulat für orale Suspension, Klacid 250 mg/5 ml - Granulat für orale SuspensionFibrinogen human
go.drugbank.com/drugs/DB09222ApprovedInvestigationalIt is a soluble plasma glycoprotein with a molecular weight of about 340 kDa and is a physiological substrate for three enzymes: plasmin, factor XIIIa, and thrombin. … It is indicated for the treatment of acute bleeding episodes in patients with both acquired and congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.[L41065]
Mixtures: ARTISS - Lösungen für einen Gewebekleber, Tisseel - Lösungen für einen GewebekleberProducts: HAEMOCOMPLETTAN P POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL, Fibryga 1g Powder and Solvent for Solution for Injection or InfusionMycophenolate mofetil
go.drugbank.com/drugs/DB00688ApprovedInvestigational[L7363] It is marketed by Roche Pharmaceuticals and was granted FDA approval for the prophylaxis of transplant rejection in 1995. … [A180826] In addition to the above uses, mycophenolate mofetil has also been studied for the treatment of nephritis and other complications of autoimmune diseases.
Products: Mycophenolatmofetil Accord 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, CELLCEPT FOR I.V. INFUSION 500 mg/vial